Medifarmsoft, the company was decided as a target company for government policy funding for R&D by the Ministry of Science and Technology (NIPA) in 2019. Through this project, the company has succeeded in commercializing technology and products by researching and developing for electrocardiogram measurement device, analysis, and diagnostic (reading) algorithm of arrhythmia disease based on AI technology. Therefore, the company aims to enter the global market with ECG products and services from 2021 worldwide.